Does Fluvastatin Improve Arterial Functions in Dyslipidemic Renal Transplant Recipients?

被引：0
|
作者：
Ersoy, Alparslan [1 ]
Eryilmaz, Salih [2 ]
Yildiz, Abdulmecit [3 ]
Ersoy, Canan [4 ]
Gul, Bulent Cuma [5 ]
Baran, Ibrahim [6 ]
机构：
[1] Uludag Univ, Sch Med, Dept Nephrol, TR-16059 Bursa, Turkey
[2] Kutahya State Hosp, Dept Cardiol, Kutahya, Turkey
[3] Cekirge State Hosp, Div Nephrol, TR-16052 Osmangazi, Bursa, Turkey
[4] Uludag Univ, Sch Med, Dept Endocrinol, TR-16059 Bursa, Turkey
[5] Uludag Univ, Sch Med, Dept Nephrol, TR-16059 Bursa, Turkey
[6] Uludag Univ, Sch Med, Dept Cardiol, TR-16059 Bursa, Turkey
来源：
BIOMEDICAL RESEARCH-INDIA | 2014年 / 25卷 / 02期
关键词：
Arterial stiffness; statin; renal transplant; dyslipidemia; PULSE-WAVE VELOCITY; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; CONTROLLED-TRIAL; STIFFNESS; STATINS; DISTENSIBILITY; ATORVASTATIN; THERAPY;
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Renal transplant recipients (RTRs) have increased cardiovascular (CV) risk. Arterial stiffness (AS) contributes to the occurrence of CV disease. We aimed to examine the effect of fluvastatin on CV risk factors and AS in RTRs. Fourteen dyslipidemic RTRs were enrolled. They received daily open-label 80 mg fluvastatin therapy for 6 months. Large (C1) and small (C2) vessel compliances of the radial artery were determined by pulse wave analysis at baseline and after 6 months of treatment with fluvastatin. No significant changes in C1 or C2 measurements were observed. Total cholesterol, LDL cholesterol, and triglyceride levels decreased significantly. Our results suggest that 6-month treatment with fluvastatin in dyslipidemic RTRs was not associated with improvement in AS despite significant improvement of lipid profile.
引用
收藏
页码：157 / 160
页数：4
相关论文
共 50 条
  • [41] WITHDRAWAL OF CYCLOSPORINE FROM LIVER-TRANSPLANT RECIPIENTS IS IMMUNOLOGICALLY UNSAFE AND DOES NOT IMPROVE CHRONIC RENAL DYSFUNCTION
    HAY, JE
    PORAYKO, MK
    WIESNER, RH
    GORES, GJ
    DICKSON, ER
    WAHLSTROM, HE
    KROM, RAF
    HEPATOLOGY, 1991, 14 (04) : A53 - A53
  • [42] Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
    Holdaas, H
    Fellström, B
    Jardine, AG
    Holme, I
    Nyberg, G
    Fauchald, P
    Grönhagen-Riska, C
    Madsen, S
    Neumayer, HH
    Cole, E
    Maes, B
    Ambühl, P
    Olsson, AG
    Hartmann, A
    Solbu, DO
    Pedersen, TR
    LANCET, 2003, 361 (9374): : 2024 - 2031
  • [43] Monitoring of peripheral blood cytotoxic T-cells under fluvastatin treatment in renal transplant recipients
    Barlage, S
    Hauser, IA
    Elbracht, R
    Abletshauser, C
    Schmieder, RE
    Weidinger, G
    Lackner, KJ
    Rothe, G
    Schmitz, G
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2005, 19 (3-4): : 159 - 168
  • [44] LONG TERM EFFECTIVENESS AND SAFETY OF FLUVASTATIN IN RENAL TRANSPLANT RECIPIENTS: THE ALERT TRIAL FOLLOW-UP
    Holdaas, Hallvard
    Fellstrom, Bengt
    Jardin, Alan
    Cole, Edward
    Nyberg, Gudrun
    Gronhagen-Riska, Carola
    Maes, Bart
    Neumayer, Hans-Hellmut
    Madsen, Soren
    Ambuehl, Patrick
    Olsson, Anders
    Pedersen, Terje
    NEPHROLOGY, 2005, 10 : A88 - A89
  • [45] Nutritional management in renal transplant recipients: A transplant team opportunity to improve graft survival
    Sabbatini, M.
    Ferreri, L.
    Pisani, A.
    Capuano, I
    Morgillo, M.
    Memoli, A.
    Riccio, E.
    Guida, B.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (04) : 319 - 324
  • [46] Obesity, Fat Tissue Parameters, and Arterial Stiffness in Renal Transplant Recipients
    Heleniak, Zbigniew
    Illersperger, Sarah
    Brakemeier, Susanne
    Debska-Slizien, Alicja
    Budde, Klemens
    Halleck, Fabian
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2341 - 2346
  • [47] ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND BLOOD PRESSURE IN RENAL TRANSPLANT RECIPIENTS
    Hannah, Hessamodini
    Andrea, Viecelli
    Germaine, Wong
    Wai, Lim
    IMMUNOLOGY AND CELL BIOLOGY, 2013, 91 (08): : A37 - A37
  • [48] Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients
    Kneifel, M.
    Scholze, A.
    Burkert, A.
    Offermann, G.
    Rothermund, L.
    Zidek, W.
    Tepel, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (07) : 1624 - 1630
  • [49] Influence of Erythropoietin on Arterial Stiffness and Endothelial Function in Renal Transplant Recipients
    Bartels, Valerie
    Hillebrand, Uta
    Kosch, Markus
    Hausberg, Martin
    Kisters, Klaus
    Di Marco, Giovana Seno
    Reiermann, Stefanie
    Pavenstaedt, Hermann
    Lang, Detlef
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (04) : 355 - 361
  • [50] Arterial Stiffness Is Associated With Increased Mortality in Renal Transplant Recipients.
    Eide, I.
    Aasberg, A.
    Jenssen, T.
    Holdaas, H.
    Dahle, D.
    von During, M.
    Pihlstrom, H.
    Hartmann, A.
    TRANSPLANTATION, 2014, 98 : 517 - 517
12345